Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.49 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.44 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9420717 | 0.98 | NAAA (0.53) | NAAADGKAHTR2CDNM1ALDH1A1 | |
| SCHEMBL9420754 | 0.98 | NAAA (0.53) | NAAADGKAHTR2CDNM1ALDH1A1 | |
| SCHEMBL2871598 | 0.94 | DGKA (0.52) | NAAADGKAHTR2CDNM1ALDH1A1 | |
| SCHEMBL19733720 | 0.92 | NAAA (0.50) | NAAADGKAHTR2CDNM1ALDH1A1 | |
| SCHEMBL421653 | 0.89 | NAAA (0.60) | NAAADGKAHTR2CDNM1ALDH1A1 | |
| SCHEMBL9420819 | 0.88 | DGKA (0.62) | NAAADGKAHTR2CDNM1ALDH1A1 | |
| SCHEMBL420094 | 0.87 | NAAA (0.64) | NAAADGKAHTR2CDNM1ALDH1A1 | |
| Pentane-1,5-Dibutanoate SCHEMBL15705199 | 0.87 | NAAA (0.64) | NAAADGKAHTR2CDNM1ALDH1A1 | |
| SCHEMBL10887322 | 0.87 | HTR2C (0.46) | NAAADGKAHTR2CDNM1ALDH1A1 | |
| SCHEMBL10961476 | 0.86 | DGKA (0.71) | NAAADGKAHTR2CDNM1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150021528-A1 | SOLUBLE FUNCTIONALIZED NANOPARTICLES FOR USE IN OPTICAL MATERIALS | STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF UNIVERSITY (US) | 2015-01-22 | — | — | US | claimed |
| EP-1570835-B1 | Composition for the permanent deformation of the hair comprising at least one carboxydithiol | OREAL (FR) | 2010-10-20 | — | — | EP | claimed |
| US-9513406-B2 | Soluble functionalized nanoparticles for use in optical materials | UNIVERSITY OF OREGON (US) | 2016-12-06 | — | — | US | disclosed |
| US-20150021528-A1 | SOLUBLE FUNCTIONALIZED NANOPARTICLES FOR USE IN OPTICAL MATERIALS | STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF UNIVERSITY (US) | 2015-01-22 | — | — | US | disclosed |
| US-20150023643-A1 | GRADIENT OPTICAL POLYMER NANOCOMPOSITES | State of Oregon acting by and through the State Board of Higher Education on behalf of the Univers (US) | 2015-01-22 | — | — | US | disclosed |
| US-20060276669-A1 | Process for preparing sulfonated arylphosphines | CELANESE CHEMICALS EUROPE GMBH | 2006-12-07 | — | — | US | disclosed |
| US-7102034-B2 | Process for preparing sulfonated arylphosphines | CELANESE CHEMICALS EUROPE GMBH (DE) | 2006-09-05 | — | — | US | disclosed |
| US-20050171377-A1 | Process for preparing sulfonated arylphosphines | CELANESE CHEMICALS EUROPE GMBH | 2005-08-04 | — | — | US | disclosed |
| US-6864387-B2 | Process for preparing sulfonated arylphosphines | CELANESE CHEMICALS EUROPE GMBH (DE) | 2005-03-08 | — | — | US | disclosed |
| US-20040019236-A1 | Process for preparing sulfonated arylphosphines | CELANESE CHEMICALS EUROPE GMBH | 2004-01-29 | — | — | US | disclosed |
| US-6610881-B1 | Following reaction diluting with water and fedding inert gas stream through solution until sulfur dioxide is no longer liberated | CELANESE CHEMICALS EUROPE (DE) | 2003-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060276669-A1 | Process for preparing sulfonated arylphosphines | ARSA, SNRK, SMOX | NAAA 276/4885DGKA 1842/4885HTR2C 3805/4885 |
| US-20040019236-A1 | Process for preparing sulfonated arylphosphines | SKP1, TST, ARSA | NAAA 828/4885DGKA 2529/4885HTR2C 4555/4885 |
| US-20050171377-A1 | Process for preparing sulfonated arylphosphines | SKP1, ARSA, OSR1 | NAAA 620/4885DGKA 1666/4885HTR2C 3777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.